• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Third party research

Atria: Strong top-line momentum continues - Nordea

Atria

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Atria's Q1 was solid with adjusted EBIT beating LSEG Data & Analytics consensus by 6%. Higher subsidies supported the development in Estonia, while an avian influenza-driven shortage of poultry impacted sales and earnings negatively in Sweden. Ahead of the important grilling season, Atria has strong top-line momentum, while we note that rising cost inflation could put slight pressure on earnings before pricing actions are possible. We make only minor estimate revisions and nudge up our DCF- and multiples-based fair value range to EUR 18.1-22.1 (17.7-21.6).